AOD-9604
AOD-9604 (hGH Fragment 176-191)
Modified Growth Hormone Fragment for Fat Loss
What is AOD-9604?
AOD-9604 (Advanced Obesity Drug) is a modified fragment of human growth hormone (hGH), specifically the amino acids 176-191 of the hGH polypeptide. It was developed to isolate the fat-burning properties of growth hormone without the adverse effects associated with full-length hGH, such as insulin resistance and increased IGF-1 levels.
AOD-9604 works by mimicking the way natural growth hormone regulates fat metabolism. It stimulates lipolysis (the breakdown of fat) and inhibits lipogenesis (the formation of new fat). Unlike full hGH, AOD-9604 does not affect blood sugar levels or promote cell proliferation, making it a safer option for targeted fat reduction.
Research has shown that AOD-9604 has a particularly strong effect on reducing abdominal fat. It enhances the body's ability to oxidize fat for energy without stimulating appetite or causing the muscle or bone growth effects of HGH. AOD-9604 received GRAS (Generally Recognized as Safe) status from the FDA in 2007 for use as a food supplement.
Research Supply
Source high-purity AOD-9604 for your research
Dosage Guide
Route: Subcutaneous injection, once daily
Dosing Schedule
| Period | Dose |
|---|---|
| Standard dose | 300 mcg daily |
| Higher dose (advanced) | 500 mcg daily (as directed) |
Reconstitution
Injection Volumes
| Dose | Volume | Syringe Units |
|---|---|---|
| 250 mcg | 0.1 mL | 10 units |
| 300 mcg | 0.12 mL | 12 units |
| 500 mcg | 0.2 mL | 20 units |
Administration Tips
- Inject subcutaneously in the abdomen for best results
- Administer first thing in the morning on an empty stomach
- Wait at least 30 minutes before eating after injection
- Rotate injection sites to prevent irritation
- Store reconstituted solution refrigerated and use within 28 days
Risks & Side Effects
Commonly Reported
Serious Risks
Allergic reactions
Swelling, difficulty breathing, or rash; discontinue immediately if these occur.
Chest tightness
Rare; discontinue use and consult a doctor.
Hypoglycemia
Very rare, as AOD-9604 does not significantly impact blood sugar.
Contraindications
- Known hypersensitivity to AOD-9604 or any component
- Active cancer or history of cancer (as a precaution with any growth hormone fragment)
- Pregnancy or breastfeeding
- Children and adolescents (not studied in this population)
Frequently Asked Questions
Related Peptides
Experts Covering AOD-9604
LEGAL DISCLAIMER
The information provided on this page is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any peptide therapy. Individual results may vary. Peptides Institute is not responsible for any adverse effects resulting from the use of information provided on this site.